InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-30.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Lundberg Jan M, Director. Director active across 2 companies, notably Ardelyx, INC.. In total, 7 reports have been published. History available since 16 June 2021. The latest transaction was disclosed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
12,755 shares0Common StockSEC:0001628280-23-022559:0
91,240 shares0Common StockSEC:0001567619-22-013083:0
7,181 shares0Common StockSEC:0001567619-21-012427:0
7,181 shares0Common StockSEC:0001567619-21-012427
15,541 sharesCommon StockSEC:0000059478-16-000300:0
7,308 sharesCommon StockSEC:0000059478-16-000300:1
29,081 sharesCommon StockSEC:0000059478-16-000271:0
7 of 7 declarations
About Lundberg Jan M
Jan M. Lundberg is a Director of ARDELYX, INC. In this role, he participates in the governance of the company and strategic direction. ARDELYX, INC. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. Jan brings valuable expertise in leadership and strategy.
